These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30704458)

  • 1. Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
    Chiu YC; Chen HH; Zhang T; Zhang S; Gorthi A; Wang LJ; Huang Y; Chen Y
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):18. PubMed ID: 30704458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    Huang S; Hu P; Lakowski TM
    BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DeepDSC: A Deep Learning Method to Predict Drug Sensitivity of Cancer Cell Lines.
    Li M; Wang Y; Zheng R; Shi X; Li Y; Wu FX; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):575-582. PubMed ID: 31150344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer.
    Wang C; Zhang M; Zhao J; Li B; Xiao X; Zhang Y
    Comput Biol Med; 2023 Sep; 163():107220. PubMed ID: 37406589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRN-CDR: A cancer drug response prediction model using multi-omics and drug features.
    Saranya KR; Vimina ER
    Comput Biol Chem; 2024 Oct; 112():108175. PubMed ID: 39191166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.
    Pang W; Chen M; Qin Y
    BMC Bioinformatics; 2024 May; 25(1):182. PubMed ID: 38724920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis gene-related, neural network-based prognosis prediction and drug-target prediction for KIRC.
    Liu Y; Shao Y; Hao Z; Lei X; Liang P; Chang Q; Wang X
    Cancer Med; 2024 Jan; 13(1):e6763. PubMed ID: 38131663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting drug activity against cancer through genomic profiles and SMILES.
    Abbasi M; Carvalho FG; Ribeiro B; Arrais JP
    Artif Intell Med; 2024 Apr; 150():102820. PubMed ID: 38553160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. kESVR: An Ensemble Model for Drug Response Prediction in Precision Medicine Using Cancer Cell Lines Gene Expression.
    Majumdar A; Liu Y; Lu Y; Wu S; Cheng L
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting drug response through tumor deconvolution by cancer cell lines.
    Hsu YC; Chiu YC; Lu TP; Hsiao TH; Chen Y
    Patterns (N Y); 2024 Apr; 5(4):100949. PubMed ID: 38645769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A performance evaluation of drug response prediction models for individual drugs.
    Park A; Lee Y; Nam S
    Sci Rep; 2023 Jul; 13(1):11911. PubMed ID: 37488424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network.
    Liu P; Li H; Li S; Leung KS
    BMC Bioinformatics; 2019 Jul; 20(1):408. PubMed ID: 31357929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting and characterizing a cancer dependency map of tumors with deep learning.
    Chiu YC; Zheng S; Wang LJ; Iskra BS; Rao MK; Houghton PJ; Huang Y; Chen Y
    Sci Adv; 2021 Aug; 7(34):. PubMed ID: 34417181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. shinyDeepDR: A user-friendly R Shiny app for predicting anti-cancer drug response using deep learning.
    Wang LJ; Ning M; Nayak T; Kasper MJ; Monga SP; Huang Y; Chen Y; Chiu YC
    Patterns (N Y); 2024 Feb; 5(2):100894. PubMed ID: 38370127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Deep Learning Model for Cell Growth Inhibition IC50 Prediction and Its Application for Gastric Cancer Patients.
    Joo M; Park A; Kim K; Son WJ; Lee HS; Lim G; Lee J; Lee DH; An J; Kim JH; Ahn T; Nam S
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network-based drug sensitivity prediction.
    Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TransCDR: a deep learning model for enhancing the generalizability of drug activity prediction through transfer learning and multimodal data fusion.
    Xia X; Zhu C; Zhong F; Liu L
    BMC Biol; 2024 Oct; 22(1):227. PubMed ID: 39385185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel deep learning framework for accurate melanoma diagnosis integrating imaging and genomic data for improved patient outcomes.
    Kiran A; Narayanasamy N; Ramesh JVN; Ahmad MW
    Skin Res Technol; 2024 Jun; 30(6):e13770. PubMed ID: 38881051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.